
CPHI Milan 2026
10/2026 – 10/2026


Dermago grants licensing rights for its self-developed generic approvals of Advantan/Skinatan and Skinoren/Beloren, as well as exclusive licensing rights for its patent-protected product Veregen.

No hay comentarios disponibles.
Deja tu valoración & comentario